TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down | Nasdaq
Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product | Investor's Business Daily
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption (NYSE: TEVA) | Seeking Alpha
Teva Pharmaceuticals Near 20-Year Lows (NYSE:TEVA) | Seeking Alpha
What's in the Cards for Teva (TEVA) This Earnings Season?
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva stock plummets 18% after rough quarter in US generic drug market
:max_bytes(150000):strip_icc()/TEVA-Chart-02142019-5c65830bc9e77c0001d93394.png "Where Are Teva Shares Headed After the Q4 Decline?")
Where Are Teva Shares Headed After the Q4 Decline?
Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings?
Teva stock plummets 18% after rough quarter in US generic drug market
TEVA Stock Declines Despite Q4 Earnings and Sales Beat
Teva Pharmaceutical: An Opportunity Or A Falling Knife? (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical: An Opportunity Or A Falling Knife? (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical: An Opportunity Or A Falling Knife? (NYSE:TEVA) | Seeking Alpha
Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
Teva Shares Fall Further as Morgan Stanley Downgrades Rating
TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
TEVA Stock Declines Despite Q4 Earnings and Sales Beat
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Forget Teva (TEVA), Buy These 4 Drug Stocks Instead
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
